Pursuant to the provisions of Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, we would like to inform you that at the meeting of Board of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Phyto Chem (India) Limited informed BSE about the outcome of its Board meeting held on 14 November 2025. The Board approved the Unaudited Financial Results for the second quarter and half-year ended 30 September 2025. No other major business decisions such as dividend, fundraising, or M&A were mentioned. The meeting lasted about 4 hours and 15 minutes, from 4:00 PM to 8:15 PM. The intimation was signed by Executive Director Y. Janaki Ramaiah.
This is a routine quarterly compliance filing and does not signal any major corporate action. Investors should wait for the detailed Q2 financial numbers for actual insights into the company's performance.